Inside Innovation

The Allen Institute, a Seattle-based research institute, has introduced new stem cell lines that could help scientists identify personalized treatment approaches for Hypertrophic cardiomyopathy (HCM),

According to CBRE’s third-annual U.S. Life Sciences Talent Trends report, the Seattle area ranks as a top market for life science graduates. The report notes a 15.1%

Researchers at Microsoft, Providence Health System and the University of Washington have developed a new artificial intelligence model for diagnosing cancer, based on an analysis

According to data from a recently released late-stage trial, treatment with Bristol Myers Squibb’s immunotherapies, Opdivo and Yervoy, had better outcomes for patients than the

Vilya, a biotech startup built from technology developed at the Seattle-based Institute for Protein Design (IPD), announced an expanded $71 million Series A investment round. The

Washington Research Foundation (WRF) awarded nearly $2.2 million in grants to 12 teams at Fred Hutch, Seattle Hub for Synthetic Biology, University of Washington, and

AGC Biologics, a global contract development and manufacturing organization based in Seattle, announced a new partnership with BioConnection, a specialized contract manufacturing organization, to provide

According to the first-ever “Global Cities Index” report from Oxford Economics, Seattle ranks No. 6 out of 1,000 of the world’s largest cities. The ranking

A-Alpha Bio, a Seattle-based biotechnology company, announced the Department of Defense has awarded the company another $14.5 million to accelerate its antibody discovery and optimize

Bristol Myers Squibb received expanded FDA approval for cancer cell therapy Breyanzi, to treat adults with a type of blood cancer called follicular lymphoma that

This week, funds began flowing to local cancer research institutions as part of a $1 million grant towards ovarian cancer research in the state, awarded